After convincing Li Linzhang, Zhou Yang was in a good mood.
Domestic assistance in the production of the little blue pill is of extraordinary significance to Yuanwei Company and the entire Scythe Project.
At present, the little blue pill has just been launched on Hong Kong Island, and the entire market is still in a state of short supply.
Under such circumstances, no matter how high the output in China or Hong Kong Island is, it can be converted into valuable foreign exchange in the face of huge demand. This is definitely holding money in a sack, and it is a rare opportunity.
It's just that there aren't many people in China who know how to produce the little blue pills. Apart from Zhou Yang himself, only Li Linzhang has this ability.
If Li Linzhang cannot be persuaded to come forward to guide the production of Little Blue Pill, then Zhou Yang will have no choice but to go to Yangcheng himself.
But the problem is that spring has just begun here in Saibei Province. Whether it is the village or the research institute, there are so many places that need him, and Zhou Yang really can't leave.
Therefore, after receiving a call from Lu Zhengjun, the first thing Zhou Yang thought of was to ask Li Linzhang to take a walk.
It's just that he is not sure about this matter. He knows how resistant Li Linzhang is to such "irregular" drugs.
As a professor of medicine, Li Linzhang has a nominal reserve and the aloofness of an intellectual. Although he created the little blue pill according to his idea, he is unwilling to have anything to do with this drug.
Seeing his avoidant expression, Zhou Yang was really afraid that he couldn't convince him.
Fortunately, Li Linzhang was an old comrade with a broad perspective. Although he still didn't accept the medicine, he still agreed to go to Yangcheng after learning that it was an order from a superior department.
This made Zhou Yang feel relieved!
Zhou Yang was in a good mood and did not choose to leave immediately. After settling the matter, he immediately came to the nearby Saibei Medical Research Center accompanied by Li Linzhang, Zhong Qi and others.
After learning that Zhou Yang was coming, Song Shi, Yang Chunhua, Duan Yingzhong and others all put down their work and rushed over. After all, this was the director of the Medical Research Center.
After walking around the research center, at Zhou Yang's request, the group came to the conference room of the research center, and a small-scale internal meeting began immediately.
The conference room was crowded. In addition to Zhou Yang, Song Shi, Yang Chunhua, Duan Yingzhong, Zhong Qi and others were all present. Everyone formed an oval with Zhou Yang as the center.
After everyone arrived, Zhou Yang looked around. Wherever his eyes passed, everyone fell silent instantly.
"Comrades, it has been almost a year since our Saibei Medical Research Center was established. After this year's development, the changes have been very big. This time I came here and saw many new faces. Some of them I can't even name. Come on with the name, and ask Professor Song to tell us the basic situation here!"
Even though Zhou Yang is the director of this medical research center, in the past nearly a year, the number of times Zhou Yang has come here is very limited and can be counted on the palm of his hand.
Song Shi, who was responsible for daily work, was a research scholar. If there was nothing particularly important, he would not bother Zhou Yang.
Therefore, Zhou Yang really didn't know much about the situation at Saibei Medical Center.
Of course, this cannot be blamed on Zhou Yang's irresponsibility. The main reason is that medical research is completely different from research and development in other fields.
Since medicine is ultimately intended for human use and is a major matter related to the safety of thousands of people's lives, more caution is required during research and development, which results in a longer research and development cycle.
From project establishment to producing results to applying for drug marketing, it may take two or three years at a shorter time, and it may take more than ten years or even decades at a long time.
And Zhou Yang's time is so precious, he really doesn't have that much time to devote to the field of medical research and development.
Hearing Zhou Yang's roll call, Deputy Director Song Shi coughed slightly, and then said: "Indeed, we have had many newcomers here recently, including Professor Tao, the pioneer in the development of the domestic hepatitis B vaccine, and the director of liver disease research at Beijing Medical College. Comrade Lu Xuefeng, as well as Comrades Hou Tianming and Li Bingyi from the Liu Research Institute, our team has grown a lot now, and it is no longer the Caotai team before!"
"Currently, our Saibei Research Center has 8 departments, 87 formal employees, and 76 intern employees. It can be considered a medium-sized medical research center! In addition to personnel, finance, security and other departments, we also include 3 project teams and a Directly affiliated health center open to the public!"
"As of now, our medical research and development center is working on two projects, one is the development of a second-generation hepatitis B vaccine, and the other is the development of a vaccine for Haemophilus influenzae type B infection..."
After listening to Song Shi's brief report, Zhou Yang couldn't help but nodded.
Although except for the little blue pill, there are no other scientific research results available here for the time being, but in terms of development momentum, it is still good.
"Professor Song, how are the progress of the two R&D projects here?" Zhou Yang asked immediately.
"The progress of the second-generation hepatitis B vaccine is quite smooth. At present, we have successfully used yeast DNA to recombinantly produce human hepatitis B surface antigen protein."
Then Song Shi said again: "Although the technology for cultivating antigen proteins is not very stable at present, the experimental results are very good. The vaccine cultivated using this method has a strong preventive effect against hepatitis B virus. It can be determined Our research direction is right!”
Zhou Yang was also very happy to hear that the research team had cultivated the antigen protein of hepatitis B, which meant that there had been a major breakthrough in the research on the second-generation hepatitis B vaccine.
After all, this is the most difficult step to overcome in the second-generation hepatitis B vaccine. As long as the research continues according to the current method, a new hepatitis B vaccine that surpasses the blood-borne vaccine should soon be produced.
Thinking of this, Zhou Yang looked at Yang Chunhua on the lower left, and then said: "Professor Yang, you are the leader of the hepatitis B vaccine research team. How long do you think it will take before the new vaccine can complete clinical trials?"
"We are confident that we can complete the first phase of clinical trials within one year!"
Then Yang Chunhua explained again: "At present, we have produced some second-generation vaccines through laboratory cultivation and have also conducted relevant tests. Overall, the effect is quite good, several times more effective than blood-borne vaccines."
"However, due to some technical problems, we can only carry out small-scale production in the laboratory, and the failure rate is very high. We do not have large-scale production at all, so in the next time, we will conduct clinical trials while We still need to further improve the process and strive to achieve mass production of our new vaccine within a year!”
Hearing this, Zhou Yang felt a little excited.
The importance of hepatitis B vaccine is self-evident, and the market prospects are even more amazing.
Hepatitis B is now a troublesome social problem not only in our country, but also in every country in the world. Not only is this disease harmful, it is also contagious.
Once it reaches a certain base, it will easily cause panic in the whole society, which Zhou Yang knows very well.
Although the blood-borne hepatitis B vaccine has been released, it is too expensive. For example, at Thief Eagle, one shot of hepatitis B vaccine costs more than $100, and the effect is not very good.
If Yang Chunhua and others can develop a real second-generation hepatitis B vaccine, not to mention how much money they can earn for the country, it will also be of great significance to us in controlling the high number of hepatitis B people in our country.
"Well, I believe you can do it. If you need anything, just ask and I will try my best to meet your requirements!" Zhou Yang said.
"yes!"
"Professor Song, how is the progress of the project you are hosting?" Zhou Yang asked again.
"The research I'm leading here is a vaccine for Haemophilus influenzae type B infection. Last year, our research team conducted laboratory cultivation of this virus, but the effect was not very good. There should be no results in a short time!" Song Shi sighed. said in a tone.
"Don't be anxious. Medical research and development itself is a slow and careful work. If you are too anxious, you won't be able to eat hot tofu in a hurry!"
Then Zhou Yang continued: "I happen to have some research on Haemophilus influenzae type B infection. We can talk about it later!"
Hearing this, Song Shi's eyes suddenly lit up, and his face showed an excited expression...
........
PS: Chapter 2 is delivered!
